LEO Pharma reports positive data from Phase III plaque psoriasis trial

cafead

Administrator
Staff member
  • cafead   May 08, 2024 at 11:12: PM
via Leo Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in Chinese adult patients with stable plaque psoriasis.

An aerosol spray foam, enstilar combines 50mcg/g calcipotriol monohydrate and 0.5mg/g betamethasone dipropionate.

article source